 |
|
Kidney disease linked to lower medication use after heart attack
July 10, 2008Patients with kidney disease-especially end-stage renal disease (ESRD) requiring dialysis-are less likely to receive recommended medications after a heart attack, reports a study in the September 2008 Clinical Journal of the American Society of Nephrology (CJASN).
"This is the first systematic report to investigate whether kidney function is associated with use of and adherence with medications that are recommended for secondary prevention after a heart attack," comments Dr. Wolfgang C. Winkelmayer of Brigham and Women's Hospital in Boston, MA. "We found that use of several medications after a heart attack was lower in patients with chronic kidney disease (CKD) or ESRD. However, 1-year adherence did not differ by kidney function."
The researchers analyzed data on medication use after a heart attack, or myocardial infarction, in approximately 21,500 patients. Seventeen percent of the patients had CKD-loss of kidney function that, in many cases, progresses to ESRD. Another two percent had ESRD-permanent loss of kidney function requiring dialysis or transplantation.
Patients with and without kidney disease were compared for use of medications recommended after myocardial infarction: beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), and cholesterol-lowering "statin" drugs. Along with aspirin, these three types of drugs are an important part of strategies to prevent further events after myocardial infarction.
Overall rates of medication use were low: after leaving the hospital, just 27 percent of patients filled a prescription for a statin drug. Forty-four percent started treatment with ACEIs/ARBs and 57 percent with beta-blockers.
After adjustment for other factors, patients with CKD were 22 percent less likely to start beta-blocker treatment, compared to patients without kidney disease. There was no difference in ACEI/ARB or statin use.
For ESRD patients, rates of medication use were even lower: 43 percent lower for ACEIs/ARBs and 17 percent lower for statins. (Patients with ESRD were also less likely to start beta-blocker treatment, although the difference wasn't significant.)
Among patients who filled a first prescription, rates of continued medication use after one year were 64 percent for beta-blockers, 57 percent for statins, and 54 percent for ACEIs/ARBs. For all three types of drugs, adherence rates were similar for patients with and without CKD. Patients with ESRD were less likely to continue beta-blocker treatment.
The results may help in understanding how medications affect the relationship between kidney disease and cardiovascular disease. "Kidney function is a well-established risk factor for cardiovascular events such as heart attacks and is also associated with a worse prognosis after such events," says Dr. Winkelmayer. "One possible explanation is differences in health service delivery-it may be that patients with more advanced kidney function receive less state-of-the art care after a heart attack, including less acute coronary intervention, less acute medical intervention, and less chronic, secondary prevention." The results also show some important differences in medication use after myocardial infarction by patients with kidney disease, particularly ESRD. However, these differences don't appear to explain the higher cardiovascular risk among patients with low kidney function.
Over time, rates of adherence to all three types of medications for myocardial infarction are surprisingly low-for patients with and without kidney disease. Especially as rates of kidney disease continue to rise, new ways of reducing cardiovascular risk among patients with low kidney function should be a top priority, the researchers conclude.
The study was limited by a lack of data on vital and laboratory measurements. This included tests to confirm the presence of kidney disease, which was ascertained from health care claims.
American Society of Nephrology
Patients with and without kidney disease were compared for use of medications recommended after myocardial infarction: beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), and cholesterol-lowering "statin" drugs. Along with aspirin, these three types of drugs are an important part of strategies to prevent further events after myocardial infarction.
Overall rates of medication use were low: after leaving the hospital, just 27 percent of patients filled a prescription for a statin drug. Forty-four percent started treatment with ACEIs/ARBs and 57 percent with beta-blockers.
After adjustment for other factors, patients with CKD were 22 percent less likely to start beta-blocker treatment, compared to patients without kidney disease. There was no difference in ACEI/ARB or statin use.
For ESRD patients, rates of medication use were even lower: 43 percent lower for ACEIs/ARBs and 17 percent lower for statins. (Patients with ESRD were also less likely to start beta-blocker treatment, although the difference wasn't significant.)
Among patients who filled a first prescription, rates of continued medication use after one year were 64 percent for beta-blockers, 57 percent for statins, and 54 percent for ACEIs/ARBs. For all three types of drugs, adherence rates were similar for patients with and without CKD. Patients with ESRD were less likely to continue beta-blocker treatment.
The results may help in understanding how medications affect the relationship between kidney disease and cardiovascular disease. "Kidney function is a well-established risk factor for cardiovascular events such as heart attacks and is also associated with a worse prognosis after such events," says Dr. Winkelmayer. "One possible explanation is differences in health service delivery-it may be that patients with more advanced kidney function receive less state-of-the art care after a heart attack, including less acute coronary intervention, less acute medical intervention, and less chronic, secondary prevention." The results also show some important differences in medication use after myocardial infarction by patients with kidney disease, particularly ESRD. However, these differences don't appear to explain the higher cardiovascular risk among patients with low kidney function.
Over time, rates of adherence to all three types of medications for myocardial infarction are surprisingly low-for patients with and without kidney disease. Especially as rates of kidney disease continue to rise, new ways of reducing cardiovascular risk among patients with low kidney function should be a top priority, the researchers conclude.
The study was limited by a lack of data on vital and laboratory measurements. This included tests to confirm the presence of kidney disease, which was ascertained from health care claims.
American Society of Nephrology
Kidney Disease Current Events and Kidney Disease News RSSHigh Blood Pressure Easy to Miss in Children with Kidney Disease
Spot blood pressure readings in children with chronic kidney disease often fail to detect hypertension - even during doctor's office visits - increasing a child's risk for serious heart problems, according to research from Johns Hopkins Children's Center and other institutions. A report of the findings appears online in the Journal of American Society of Nephrology.
New research shows versatility of amniotic fluid stem cells
For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought.
Young athletes need dual screening tests for heart defects, study suggests
To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins.
New class of molecules may help prevent fatal complication in patients with kidney disease
Researchers at the University of Maryland School of Medicine have made an important discovery about why potassium builds up to dangerous levels in the bloodstream, a relatively common medical problem that affects about eight percent of hospitalized patients.
Reduction in glycotoxins from heat-processing of foods reduces risk of chronic disease
Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status.
Help your kidneys: Pass on salt and diet soda
Individuals who consume a diet high in sodium or artificially sweetened drinks are more likely to experience a decline in kidney function, according to two papers being presented at the American Society of Nephrology's annual meeting in San Diego, California.
Can charcoal fight heart disease in kidney patients?
Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Women with chronic kidney disease more likely than men to go undiagnosed
Woman are at particular risk of their primary care physicians delaying diagnosis of chronic kidney disease (CKD), according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, California.
For dialysis patients, skinny is dangerous
Dialysis patients with low body fat are at increased risk of death-even compared to patients at the highest level of body fat percentage, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego.
Protein critical for insulin secretion may be contributor to diabetes
A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.
More Kidney Disease Current Events and Kidney Disease News Articles
 |
Coping with Kidney Disease: A 12-Step Treatment Program to Help You Avoid Dialysis by Mackenzie Walser (Author), Betsy Thorpe (Author) A revolutionary program that can indefinitely postpone the need for dialysis If you’ve been diagnosed with kidney failure, this book could save your life. If you suffer from diabetes, hypertension, obesity, or any of a host of conditions that put you at risk for kidney disease, you owe it to yourself to read what is in this book. If you are among the 60,000 North Americans who go on dialysis each year, the information in this book could substantially improve your quality of life. In Coping with Kidney Disease, a leading expert tells you, in plain English, what you need to know to: Understand kidney failure Recognize early warning signs of kidney failure Get a proper diagnosis Talk with your doctors about it Confidently evaluate treatment options Take charge... |
 |
100 Q&A About Kidney Disease and Hypertension (100 Questions & Answers about . . .) by Raymond R. Townsend (Author) High blood pressure is one of the leading causes of kidney failure. Each year, high blood pressure causes more than 25,000 new cases of kidney failure in the United States. 100 Questions & Answers About Kidney Disease and Hypertension offers authoritative, up-to-date, practical answers about kidney disease, end-stage renal disease, transplants, and dyalisis. The book is an invaluable resource for anyone coping with the physical and emotional turmoil of this condition. |
 |
Primer on Kidney Diseases (Greenberg, Primer on Kidney) by Arthur Greenberg MD (Author) This official publication of the National Kidney Foundation (NKF) covers all aspects of adult and pediatric kidney diseases and is ideal for nephrologists and non-nephrologists alike. The full-color design, high-quality photographs, and outstanding graphs and tables make information easy to access and understand. The latest management techniques and pearls from leading clinical experts-including international contributors-offer practical and authoritative guidance. Edited by Dr. Arthur Greenberg and members of the NKF Scientific Advisory Board, this state-of-the-art primer provides consistent depth of coverage, balanced discussion of controversy, and a uniform focus of information. Incorporates the latest NKF Kidney/Outcome Quality Initiative (K/DOQI) guidelines on chronic kidney... |
 |
Living Well with Kidney Disease by National Kidney Foundation of Southern California (Author), Elaine S. Kamil (Editor), MD (Editor), Ann M. Giblin (Editor), Jennifer Hocutt (Editor) The first edition of "Living Well With Kidney Disease" was developed and published by the National Kidney Foundation of Southern California. Based on the handbook "When Your Kidneys Fail" (originally published in 1982), this new and updated edition provides detailed information specifically intended for people coping with Kidney Disease and other renal failure, as well as their friends and families. The question and answer format provides a clear and manageable guide for those seeking support and answers. Among the topics covered are the principles of kidney function, methods of treatment, transplantation, and financial resources available to patients. With all of the ramifications of kidney failure and the rise of Chronic Kidney Disease and Type 2 Diabetes, there is a growing population... |
 |
Understanding Kidney Disease (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. When kidney disease occurs it can have detrimental effects on the body. It can lead to complete kidney failure requiring the need for dialysis treatments or a kidney transplant to stay alive. Knowing the symptoms of kidney disease can help doctors detect it early enough to get treatment; those with diabetes and high blood pressure should be tested yearly. Find out the other risks and warning signs in this program. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
|
Saudi Journal of Kidney Diseases and Transplantation by Saudi Ctr Organ Transplantatio Publication is a nephrology and organ transplantation journal. | |
 |
More Bio-fuel --- Less Bio-waste: Dietary Creatine Reduction Self-help Guide for People with Kidney Impairment by Wendy Jones (Author) More than 250,000 persons in the USA alone (and millions worldwide) have some form of end stage renal disease (ESRD). For the hundreds of thousands who must undergo dialysis to stay alive, excessive serum creatinine—the metabolic "waste" product of creatine, a natural component of meat, contributes to the vicious cycle of nausea, vomiting, anorexia and diminished quality of life experienced by both kidney patients, and those approaching renal failure. Through extensive research, Wendy Lou Jones (Royal Knight, Inc.) has created a unique self-help guide to assist both the kidney patient, and those approaching end stage renal failure, in break this negative cycle. The consumer friendly techniques for creatine removal, presented in 14-point font, are well detailed and... |
 |
Native Remedies Kidney Dr. and UTI-Clear ComboPack by Native Remedies The ComboPack of Kidney Dr. and UTI-Clear consists of multiple remedies that work well together to provide increased support for your condition. This ComboPack helps to improve kidney functioning and treat and prevent UTIs. The Kidney Dr. helps to improve kidney health and functioning and functioning of the urinary system while the UTI-Clear provides complete urinary tract and bladder wellness. |
 |
Canine Kidney Solution II by Healthy Pet Solutions Kidney Solution II for Dogs is a natural herbal supplement with anti-oxidants, cellular cleansing and cellular energy enhancing activities. Kidney Solution II supports healthy canine kidney function that is important for proper kidney filtration and protection from toxic damage. Depending on the severity of the canine kidney disease, Kidney Solution Booster for Dogs may be needed in conjunction with Kidney Solution II for optimum function. |
 |
Polycystic Kidney Disease Awareness Ribbon Mouse Pad by MyHeritageWear.com The Polycystic Kidney Disease Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Polycystic Kidney Disease Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Polycystic Kidney Disease Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
| © 2009 BrightSurf.com |